In addition, in sporadic thyroid cancer, Akt can be activated by a variety of mechanisms including somatic loss of PTEN expression, mutational activation of PI3K (PIK3CA), Akt1, and the expression of RET fusion proteins and RAS oncogenes20,21. The gene discussed is AKT1; the disease is thyroid cancer.